Rectum carcinoma in situ
disease diseaseOn this page
Also known as carcinoma in situ of rectumcarcinoma in situ of the rectummarked dysplasia of rectummarked dysplasia of the rectummarked rectal dysplasiarectal carcinoma in siturectum in situ carcinomasevere dysplasia of rectumsevere dysplasia of the rectumsevere rectal dysplasiastage 0 carcinoma of rectumstage 0 carcinoma of the rectumstage 0 rectal cancerstage 0 rectal cancer aJCC v6stage 0 rectal cancer aJCC v6 and v7stage 0 rectal cancer aJCC v7stage 0 rectal carcinomastage 0 rectum carcinoma
Summary
Rectum carcinoma in situ (MONDO:0004725) is a cancer. A subtype of intestine carcinoma in situ — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | rectum carcinoma in situ |
| Mondo ID | MONDO:0004725 |
| DOID | DOID:9174 |
| ICD-10-CM | D01.2 |
| ICD-11 | 1700649456 |
| NCIT | C4853 |
| SNOMED CT | 308879003 |
| UMLS | C0154062 |
| MedGen | 56335 |
| Anatomy (UBERON) | UBERON:0001052 |
| Is cancer (heuristic) | yes |
Also known as: carcinoma in situ of rectum · carcinoma in situ of the rectum · marked dysplasia of rectum · marked dysplasia of the rectum · marked rectal dysplasia · rectal carcinoma in situ · rectum in situ carcinoma · severe dysplasia of rectum · severe dysplasia of the rectum · severe rectal dysplasia · stage 0 carcinoma of rectum · stage 0 carcinoma of the rectum · stage 0 rectal cancer · stage 0 rectal cancer aJCC v6 · stage 0 rectal cancer aJCC v6 and v7 · stage 0 rectal cancer aJCC v7 · stage 0 rectal carcinoma · stage 0 rectum carcinoma
Disease family
An umbrella term covering 1 Mondo subtype.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › in situ carcinoma › intestine carcinoma in situ › rectum carcinoma in situ
Related subtypes (1): colon carcinoma in situ
Subtypes (1): anal canal carcinoma in situ
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.